- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
Chapter 15 |
537 |
|
|
Pediatric urology
Embryology: urinary tract 538
Undescended testes 540
Urinary tract infection (UTI) 542
Vesicoureteric reflux (VUR) 544
Ectopic ureter 546
Ureterocele 548
Ureteropelvic junction (UPJ) obstruction 549
Hypospadias 550
Normal sexual differentiation 552
Abnormal sexual differentiation 554
Cystic kidney disease 558
Exstrophy 560
Epispadias 562
Posterior urethral valves 564
Non-neurogenic voiding dysfunction 566
Nocturnal enuresis 568
538 CHAPTER 15 Pediatric urology
Embryology: urinary tract
Following fertilization, a blastocyte (sphere of cells) is created, which implants into the uterine endometrium on day 6. The early embryonic disc of tissue develops a yolk sac and amniotic cavity, from which are derived ectoderm, endoderm, and mesoderm.
Organ formation occurs between 3 and 10 weeks’ gestation. Most of the genitourinary tract is derived from mesoderm.
Upper urinary tract
The pronephros (precursor kidney; pro = (Gk) before), derived from an intermediate plate of mesoderm, is present at weeks 1–4. It then regresses.
The mesonephros (meso = (Gk) middle) functions at weeks 4–8 and is also associated with two duct systems—the mesonephric duct and, adjacent to this, the paramesonephric duct (para = (Gk) beside) (Fig. 15.1).
The mesonephric (Wolffian) ducts develop laterally and advance downward to fuse with the primitive cloaca (hindgut). By week 5, a ureteric bud grows from the distal part of the mesonephric ducts and induces formation of the metanephros in the overlying mesoderm (permanent kidney; meta = (Gk) after).
Branching of the ureteric bud forms the renal pelvis, calyces, and collecting ducts. Glomeruli and nephrons are created from metanephric mesenchyme.
During weeks 6–10, the caudal end of the fetus grows rapidly and the fetal kidney effectively moves up the posterior abdominal wall to the lumbar region. Urine production starts at week 10.
Thus, in both males and females, the mesonephric duct forms the ureters and renal collecting system. The paramesonephric essentially forms the female genital system (fallopian tubes, uterus, upper vagina); in males, it regresses. The mesonephric duct forms the male genital duct system (epididymis, vas deferens, seminal vesicles, central zone of prostate); in the female, it regresses.
Lower urinary tract
The mesonephric ducts and ureters drain into the cloaca (Latin = sewer), which is later subdivided into the urogenital sinus (anteriorly) and the anorectal canal (posteriorly) during weeks 4–6 (see Fig. 15.1).
The bladder is formed by the upper part of the urogenital sinus. The lower part forms the urethra in females. In males, the mesonephric ducts form the posterior urethra, and closure of the urogenital groove creates the anterior urethra.
EMBRYOLOGY: URINARY TRACT 539
Upper urinary tract
Pronephros
Mesonephric duct
Cloaca
Ureteric bud
Lower urinary tract
Urorectal septum |
|
Vesicourethral canal |
Bladder |
|
Urorectal |
|
canal |
|
urogenital |
|
sinus |
Mesonephros
Gonad
Mesonephric duct
Kidney
Ureter
Anorectal canal
Figure 15.1 Development of the upper and lower parts of the urinary tract (weeks 4–6).
540 CHAPTER 15 Pediatric urology
Undescended testes
The testes descend into the scrotum in the third trimester (passing through the inguinal canal at 24–28 weeks). Failure of testicular descent results in cryptorchidism (or undescended testes).
Incidence
Incidence is 3% at birth (unilateral > bilateral). Approximately 80% will spontaneously descend by 3 months. The incidence at 1 year is 1%.
Classification
•Retractile: an intermittent active cremasteric reflex causes the testis to retract up and out of the scrotum.
•Ectopic (<5%): abnormal testis migration below the external ring of the inguinal canal (to perineum, base of penis, or femoral areas)
•Incomplete descent (~95%): testis may be intra-abdominal, inguinal, or prescrotal
•Atrophic/absent
Risk factors
These include preterm infants, low birth weight, small for gestational age, and twins.
Etiology
This includes abnormal testis or gubernaculum (tissue that guides the testis into the scrotum during development); endocrine abnormalities (low level of androgens, human chorionic gonadotrophin [hCG], luteinizing hormone (LH), calcitonin gene–related peptide); and decreased intraabdominal pressure (prune-belly syndrome, gastroschisis).
Pathology
There is degeneration of Sertoli cells, loss of Leydig cells, and atrophy and abnormal spermatogenesis.
Long-term complications
•Relative risk of cancer is 40-fold higher in the undescended testis. Most are seminomas; carcinoma in situ represents a small percentage (~2%). There is a slightly increased risk of cancer in the contralateral, normally descended testis.
•Reduced fertility
•Increased risk of testicular torsion
•Increased risk of direct inguinal hernias (due to a patent processus vaginalis)
Management
Full examination is required to elucidate if the testis is palpable and to identify location. Assess for associated congenital defects. If neither testis is palpable, consider chromosome analysis (to exclude an androgenized female) and hormone testing (high LH and FSH with a low testosterone indicates anorchia).
UNDESCENDED TESTES 541
Treatment should be performed within the first year. Hormone therapy (hCG, LHRH) stimulates testosterone production. Surgery consists of inguinal exploration, mobilization of spermatic cord, ligation of processus vaginalis, and securing the testis into a dartos pouch in the scrotal wall (orchidopexy). Laparoscopy can be used in planning surgery and for treatment.
Intra-abdominal testes may require division of spermatic vessels to provide extra length (Fowler-Stevens procedure, relying on collateral blood flow from vas), two-stage procedures, or microvascular autotransplantation.